Our team of experts brings you cancer-related?news, features, and survivor stories.
For the latest news about research we conduct and fund, see 草莓影视 Research News.
Published on: April 22, 2020
The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene.